{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:32:07Z","timestamp":1763141527678},"reference-count":25,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,3,30]]},"DOI":"10.1536\/ihj.20-611","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T22:07:10Z","timestamp":1614982030000},"page":"312-319","source":"Crossref","is-referenced-by-count":1,"title":["Risks of Ischemic Stroke\/Transient Ischemic Attack Based on CHA&lt;sub&gt;2&lt;\/sub&gt;DS&lt;sub&gt;2&lt;\/sub&gt;-VASc Scores in Non-Atrial Fibrillation Chinese Patients with Sinus Rhythm"],"prefix":"10.1536","volume":"62","author":[{"given":"Jiatian","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Dalian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tesfaldet Habtemariam","family":"Hidru","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular, First Affiliated Hospital of Dalian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular, First Affiliated Hospital of Dalian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Dalian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Dalian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengguo","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Dalian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xumin","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Dalian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan Hospital, Hebei United University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Dalian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Wang W, Jiang B, Sun H, <i>et al<\/i>. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation 2017; 135: 759-71.","DOI":"10.1161\/CIRCULATIONAHA.116.025250"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Berger JS, Peterson E, Lalibert\u00c9 F, <i>et al<\/i>. Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation. J Card Fail 2019; 25: 436-47.","DOI":"10.1016\/j.cardfail.2018.03.012"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Li YG, Lip GYH. Stroke prevention in atrial fibrillation: state of the art. Int J Cardiol 2019; 287: 201-9.","DOI":"10.1016\/j.ijcard.2018.09.057"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kirchhof P, Benussi S, Kotecha D, <i>et al<\/i>. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893-962.","DOI":"10.1093\/eurheartj\/ehw210"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mazzone C, Cioffi G, Carriere C, <i>et al<\/i>. Predictive role of CHA (2). DS (2) -VASc score for cardiovascular events and death in patients with arterial hypertension and stable sinus rhythm. Eur J Prev Cardiol 2017; 2415: 1584-93.","DOI":"10.1177\/2047487317726068"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wolsk E, Lamberts M, Hansen ML, <i>et al<\/i>. Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: A nationwide cohort study. Eur J Heart Fail 2015; 17: 828-36.","DOI":"10.1002\/ejhf.309"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Parsons C, Patel SI, Cha S, <i>et al<\/i>. CHA (2). DS (2) -VASc score: A predictor of thromboembolic events and mortality in patients with an implantable monitoring device without atrial fibrillation. Mayo Clin Proc 2017; 923: 360-9.","DOI":"10.1016\/j.mayocp.2016.10.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yang X, Hidru TH, Wang B, <i>et al<\/i>. The link between elevated long-term resting heart rate and SBP variability for all-cause mortality. J Hypertens 2019; 37: 84-91.","DOI":"10.1097\/HJH.0000000000001857"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Levey AS, Stevens LA, Schmid CH, <i>et al<\/i>. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Allan V, Banerjee A, Shah AD, <i>et al<\/i>. Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care. Heart 2017; 103: 210-8.","DOI":"10.1136\/heartjnl-2016-309910"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lau KK, Chan PH, Yiu KH, <i>et al<\/i>. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: risk of new occurrence of atrial fibrillation and ischemic stroke. Cardiol J 2014; 21: 474-83.","DOI":"10.5603\/CJ.a2014.0034"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hudzik B, Szkodzi\u0144ski J, Hawranek M, <i>et al<\/i>. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation. Acta Diabetol 2016; 53: 807-15.","DOI":"10.1007\/s00592-016-0877-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hornero F, Martin E, Paredes F, <i>et al<\/i>. Stroke after coronary artery bypass grafting: preoperative predictive accuracies of CHADS2 and CHA2DS2VASc stroke risk stratification schemes. J Thorac Cardiovasc Surg 2012; 144: 1428-35.","DOI":"10.1016\/j.jtcvs.2012.07.053"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ye S, Qian M, Zhao B, <i>et al<\/i>. CHA (2) DS (2) -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm. Eur J Heart Fail 2016; 1810: 1261-6.","DOI":"10.1002\/ejhf.613"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Suzuki S, Yamashita T, Okumura K, <i>et al<\/i>. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy-pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. Circ J 2015; 792: 432-8.","DOI":"10.1253\/circj.CJ-14-1131"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chao TF, Liu CJ, Wang KL, <i>et al<\/i>. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?. J Am Coll Cardiol 2015; 65: 635-42.","DOI":"10.1016\/j.jacc.2014.11.046"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. van den Ham HA, Klungel OH, Singer DE, <i>et al<\/i>. Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a national primary care database. J Am Coll Cardiol 2015; 66: 1851-9.","DOI":"10.1016\/j.jacc.2015.08.033"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chan YH, Yiu KH, Lau KK, <i>et al<\/i>. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Atherosclerosis 2014; 237: 504-13.","DOI":"10.1016\/j.atherosclerosis.2014.08.026"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Chou YL, Liou JT, Cheng CC, <i>et al<\/i>. The association of ischaemic stroke in patients with heart failure without atrial flutter\/fibrillation. Heart 2020; 106: 616-23.","DOI":"10.1136\/heartjnl-2019-315646"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol 2020; 17: 269-85.","DOI":"10.1038\/s41569-019-0315-x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997; 29: 1074-80.","DOI":"10.1016\/S0735-1097(97)00019-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. B\u00e4ck M, Yurdagul A Jr, Tabas I, \u00d6\u00f6rni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 2019; 16: 389-406.","DOI":"10.1038\/s41569-019-0169-2"},{"key":"23","unstructured":"23. Candelario-Jalil E. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 2009; 10: 644-54."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zannad F, Anker SD, Byra WM, <i>et al<\/i>. Rivaroxaban in patients with heart failure, Sinus Rhythm, and Coronary Disease. N Engl J Med 2018; 379: 1332-42.","DOI":"10.1056\/NEJMoa1808848"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mehra MR, Vaduganathan M, Fu M, <i>et al<\/i>. A comprehensive analysis of the effects of Rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Eur Heart J 2019; 40: 3593-602.","DOI":"10.1093\/eurheartj\/ehz427"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/2\/62_20-611\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T04:01:58Z","timestamp":1617422518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/2\/62_20-611\/_article"}},"subtitle":["A Large-Scale Observational Study Using Kailuan Cohort Data"],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-611","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}